However, an opposite trend can be seen in the cancers like LGG, DLBC, ESCA, GBM, PAAD, LUAD, SKCM, and TGCT, i.e., low expression levels of ACE2 in these cancers are directly correlated with the overall survival of the patients. Here, ACE2 is linked to cancer.